DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

LinksSchließen

Referenz

Nauck MA, Meininger G, Sheng D et al.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

Diabetes Obes Metab 2007;
9: 194-205

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: